Accounting for expected attrition in the planning of cluster randomized trials for assessing treatment effect heterogeneity

被引:4
|
作者
Tong, Jiaqi [1 ]
Li, Fan [1 ,2 ]
Harhay, Michael O. O. [3 ]
Tong, Guangyu [1 ,2 ]
机构
[1] Yale Sch Publ Hlth, Dept Biostat, 135 Coll St, New Haven, CT 06510 USA
[2] Yale Sch Publ Hlth, Ctr Methods Implementat & Prevent Sci, New Haven, CT 06510 USA
[3] Univ Penn, Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA USA
关键词
Heterogeneity of treatment effect; Missing data; Missing at random; Missing completely at random; Power calculation; Intracluster correlation coefficient; Cluster randomized trial; SAMPLE-SIZE DETERMINATION; INTRACLASS CORRELATION-COEFFICIENT; INCOMPLETE OBSERVATIONS; LONGITUDINAL DESIGNS; POWER; ADJUSTMENTS; ESTIMATORS; SIMULATION;
D O I
10.1186/s12874-023-01887-8
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundDetecting treatment effect heterogeneity is an important objective in cluster randomized trials and implementation research. While sample size procedures for testing the average treatment effect accounting for participant attrition assuming missing completely at random or missing at random have been previously developed, the impact of attrition on the power for detecting heterogeneous treatment effects in cluster randomized trials remains unknown.MethodsWe provide a sample size formula for testing for a heterogeneous treatment effect assuming the outcome is missing completely at random. We also propose an efficient Monte Carlo sample size procedure for assessing heterogeneous treatment effect assuming covariate-dependent outcome missingness (missing at random). We compare our sample size methods with the direct inflation method that divides the estimated sample size by the mean follow-up rate. We also evaluate our methods through simulation studies and illustrate them with a real-world example.ResultsSimulation results show that our proposed sample size methods under both missing completely at random and missing at random provide sufficient power for assessing heterogeneous treatment effect. The proposed sample size methods lead to more accurate sample size estimates than the direct inflation method when the missingness rate is high (e.g., >= 30%). Moreover, sample size estimation under both missing completely at random and missing at random is sensitive to the missingness rate, but not sensitive to the intracluster correlation coefficient among the missingness indicators.ConclusionOur new sample size methods can assist in planning cluster randomized trials that plan to assess a heterogeneous treatment effect and participant attrition is expected to occur.
引用
收藏
页数:14
相关论文
共 50 条
  • [1] Accounting for expected attrition in the planning of cluster randomized trials for assessing treatment effect heterogeneity
    Jiaqi Tong
    Fan Li
    Michael O. Harhay
    Guangyu Tong
    [J]. BMC Medical Research Methodology, 23
  • [2] Correction: Accounting for expected attrition in the planning of cluster randomized trials for assessing treatment effect heterogeneity
    Jiaqi Tong
    Fan Li
    Michael O. Harhay
    Guangyu Tong
    [J]. BMC Medical Research Methodology, 23
  • [3] Accounting for expected attrition in the planning of cluster randomized trials for assessing treatment effect heterogeneity (vol 23, 85, 2023)
    Tong, Jiaqi
    Li, Fan
    Harhay, Michael O.
    Tong, Guangyu
    [J]. BMC MEDICAL RESEARCH METHODOLOGY, 2023, 23 (01)
  • [4] Accounting for expected attrition in the planning of community intervention trials
    Taljaard, Monica
    Donner, Allan
    Klar, Neil
    [J]. STATISTICS IN MEDICINE, 2007, 26 (13) : 2615 - 2628
  • [5] Accounting for unequal cluster sizes in designing cluster randomized trials to detect treatment effect heterogeneity
    Tong, Guangyu
    Esserman, Denise
    Li, Fan
    [J]. STATISTICS IN MEDICINE, 2022, 41 (08) : 1376 - 1396
  • [6] Planning stepped wedge cluster randomized trials to detect treatment effect heterogeneity
    Li, Fan
    Chen, Xinyuan
    Tian, Zizhong
    Wang, Rui
    Heagerty, Patrick J.
    [J]. STATISTICS IN MEDICINE, 2024, 43 (05) : 890 - 911
  • [7] Assessing treatment effect heterogeneity in the presence of missing effect modifier data in cluster-randomized trials
    Blette, Bryan S.
    Halpern, Scott D.
    Li, Fan
    Harhay, Michael O.
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2024, 33 (05) : 909 - 927
  • [8] Assessing exposure-time treatment effect heterogeneity in stepped-wedge cluster randomized trials
    Maleyeff, Lara
    Li, Fan
    Haneuse, Sebastien
    Wang, Rui
    [J]. BIOMETRICS, 2023, 79 (03) : 2551 - 2564
  • [9] Assessing heterogeneity of treatment effect analyses in health-related cluster randomized trials: A systematic review
    Starks, Monique Anderson
    Sanders, Gillian D.
    Coeytaux, Remy Rene
    Riley, Isaretta L.
    Jackson, Larry R., II
    Brooks, Amanda McBroom
    Thomas, Kevin L.
    Choudhury, Kingshuk Roy
    Califf, Robert M.
    Hernandez, Adrian F.
    [J]. PLOS ONE, 2019, 14 (08):
  • [10] Maximin optimal cluster randomized designs for assessing treatment effect heterogeneity
    Ryan, Mary M.
    Esserman, Denise
    Li, Fan
    [J]. STATISTICS IN MEDICINE, 2023, 42 (21) : 3764 - 3785